Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

Fuzhou Maixin Biotech Co., Ltd. (doing business as MXB Biotechnologies), part of Beijing Strong Biotechnologies, Inc., is a Chinese company located in Fuzhou. The firm engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH. It was founded in 1993. Xiao Ya Wang is the current CEO of the firm. Fuzhou Maixin Biotech Co. Ltd. acquired Fuzhou Maixin Biotech Co., Ltd. on September 30, 2020 for $255.21 million.

Konica Minolta Inc. is an Innovative Company and continues to create inspiring products and services in the field of imaging. An innovative corporation that continues to create inspiring products and services in the field of imaging. A global corporation that leads the market by advanced technologies and reliability. The Konica Minolta brand shows intellectual creativity with its challenging, reliable, friendly personality. Four unique characteristics help realize the ideal value of the brand: broad technical expertise covering the entire imaging field; a culture relentlessly committed to creating great products and services; unique product groups developed from integrated technologies; a marketing service network that swiftly copes with customers’ needs. The essence of their brand is Konica Minolta’s comprehensive technological expertise that yields highly original innovations, which are a constant source of surprise to customers. The logo is a representation of their brand value and company name and expresses what Konica Minolta offers to customers. The Konica Minolta Group owns a wide array of specialized technologies and technologies that support the competitiveness and attractiveness of their products. These technologies are defined as our core technologies, totaling twelve – four in materials, two in optics, two in nano-fabrication and four in imaging fields. Throughout their history, they have expanded and advanced these technologies, integrating them at whole new levels so that they are the driving force of our production activities. They continuously strive to integrate these technologies into innovative products with new functions and added value that contribute to the daily lives of people at home and at work. Naturally, this also includes our range of Business Solution products.

Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.

Develops products for the treatment of human immune systems disorders and diseases

Yinmai Guoke (Xiamen) Biotechnology Co., Ltd., established on 2016-02-02, Business scope includes biotechnology extension services;Other technical promotion services;Medical Research and Experimental Development;Technology intermediary service;Other unspecified technology promotion and application service industries;Natural science research and experimental development;Other unlisted professional and technical service industries(Not subject to permit approval);Other unlisted business service industry(Items not subject to permit approval).

Shengshi Jinghua (Beijing) Biotechnology Co., Ltd., established on 2018-12-06, Business scope includes certification services;Biotechnology promotion;technology development,Technical Services,technology transfer,Technology Promotion;Technical testing;Natural science research and experimental development;Agricultural Science Research and Experimental Development;Educational technology development;health management,Health Advisory(Except for medical treatment activities subject to approval);Agent import and export;Technology Import and Export;design,make,acting,Place an ad;Sell ​​laboratory equipment,Chemical Products(Free of Hazardous Chemicals),Computer hardware and software and auxiliary equipment,electronic product,Office Supplies,Wujinjiaodian(E-bike not included),Daily Chemicals,Daily necessities,Cultural and sporting goods(Except for audiovisual products),household appliances,plastic products,ceramics,rubber products,Glass product,biologics(except medicines),chemical reagent(Free of Hazardous Chemicals);Import and export,Technology Import and Export(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Certification services and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Yaneng Biotechnology produces a gene diagnostic chip technology platform. They provide cervical cancer screening and hereditary disease diagnostics, such as pre pregnancy and prenatal diagnosis and screening tests, and automatic nucleic acid extractor.  They also provide resarch and development services.

Jiangsu Provincial People's Hospital, a subsidiary of Nanjing Medical University, is a company headquartered in Guangzhou, China. The firm operates hospitals.

Hangzhou Shengyu Biomedical Technology Co., Ltd., established on 2021-08-17, Business scope includes general items:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).